Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation CC transcript Appointed director Asset disposition Quarterly results Director departure
|
ASENSUS SURGICAL, INC. (TRXC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
8-K
| Quarterly results |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/28/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
07/28/2023 |
8-K
| Quarterly results |
07/05/2023 |
4
| Shameze Rampertab (EVP, CFO) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Paid exercise price by delivering 6,975 shares
@ $0.51, valued at
$3.6k
Exercised 10,000 options to buy
@ $0 Exercised 6,666 options to buy
@ $0 |
|
06/30/2023 |
8-K
| Other Events Interactive Data |
06/08/2023 |
4
| Hobert Kevin J (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Granted 55,748 options to buy
@ $0.56, valued at
$31.2k
|
|
06/08/2023 |
4
| Kwo Elizabeth (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Granted 45,000 shares
@ $0 |
|
06/08/2023 |
4
| Milne David Bruce (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Granted 55,748 options to buy
@ $0.56, valued at
$31.2k
|
|
06/08/2023 |
4
| Biffi Andrea (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Granted 117,690 options to buy
@ $0.56, valued at
$65.9k
|
|
06/08/2023 |
4
| PFENNIGER RICHARD C JR (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Granted 45,000 shares
@ $0 |
|
06/08/2023 |
4
| Starling William N JR (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Granted 55,748 options to buy
@ $0.56, valued at
$31.2k
|
|
06/08/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
06/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/15/2023 |
8-K
| Quarterly results |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/07/2023 |
4/A
| Biffi Andrea (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Bought 293,077 shares
@ $0.7082, valued at
$207.6k
|
|
03/07/2023 |
4
| Biffi Andrea (Director) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Bought 293,077 shares
@ $0.7082, valued at
$207.6k
|
|
03/02/2023 |
8-K
| Quarterly results |
03/02/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/07/2023 |
4
| Shameze Rampertab (EVP, CFO) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Paid exercise price by delivering 103,998 shares
@ $0.75, valued at
$78k
Granted 175,000 options
@ $0.75, valued at
$131.3k
Granted 175,000 options to buy
@ $0 Granted 350,000 options to buy
@ $0 Exercised 84,270 options to buy
@ $0 Exercised 19,704 options to buy
@ $0 Exercised 62,417 options to buy
@ $0 |
|
02/07/2023 |
4
| Fernando Anthony C. J. (President and CEO) has filed a Form 4 on ASENSUS SURGICAL, INC.
Txns:
| Paid exercise price by delivering 541,726 shares
@ $0.75, valued at
$406.3k
Granted 375,000 options
@ $0.75, valued at
$281.3k
Granted 750,000 options to buy
@ $0 Granted 375,000 options to buy
@ $0 Exercised 80,000 options to buy
@ $0 Exercised 53,333 options to buy
@ $0 Exercised 234,085 options to buy
@ $0 Exercised 280,899 options to buy
@ $0 Exercised 162,300 options to buy
@ $0 |
|
01/20/2023 |
SC 13G/A
| STATE STREET CORP reports a 0.4% stake in EXIT FILING ASENSUS SURGICAL INC |
01/12/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
11/14/2022 |
8-K
| Quarterly results |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/11/2022 |
8-K
| Quarterly results |
08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|
|